These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 21354054)

  • 1. Diagnostic and prognostic value of metastasis inducer S100A4 transcripts in plasma of colon, rectal, and gastric cancer patients.
    Stein U; Burock S; Herrmann P; Wendler I; Niederstrasser M; Wernecke KD; Schlag PM
    J Mol Diagn; 2011 Mar; 13(2):189-98. PubMed ID: 21354054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Metastasis Associated in Colon Cancer 1 transcripts in gastric cancer patient plasma as diagnostic and prognostic biomarker.
    Burock S; Herrmann P; Wendler I; Niederstrasser M; Wernecke KD; Stein U
    World J Gastroenterol; 2015 Jan; 21(1):333-41. PubMed ID: 25574109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating MACC1 transcripts in colorectal cancer patient plasma predict metastasis and prognosis.
    Stein U; Burock S; Herrmann P; Wendler I; Niederstrasser M; Wernecke KD; Schlag PM
    PLoS One; 2012; 7(11):e49249. PubMed ID: 23166620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas.
    Zhao Y; Zhang T; Wang Q
    Oncol Rep; 2013 Jul; 30(1):111-8. PubMed ID: 23612849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
    Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ
    Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of plasma and tissue S100A4 protein and mRNA levels as potential markers of metastasis and prognosis in clear cell renal cell carcinoma.
    Yang H; Zhao K; Yu Q; Wang X; Song Y; Li R
    J Int Med Res; 2012; 40(2):475-85. PubMed ID: 22613408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic shRNA mediated knock down of S100A4 in colorectal cancer xenografted mice reduces metastasis formation.
    Dahlmann M; Sack U; Herrmann P; Lemm M; Fichtner I; Schlag PM; Stein U
    Oncotarget; 2012 Aug; 3(8):783-97. PubMed ID: 22878175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.
    Sack U; Walther W; Scudiero D; Selby M; Kobelt D; Lemm M; Fichtner I; Schlag PM; Shoemaker RH; Stein U
    J Natl Cancer Inst; 2011 Jul; 103(13):1018-36. PubMed ID: 21685359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RAGE mediates S100A4-induced cell motility via MAPK/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasis.
    Dahlmann M; Okhrimenko A; Marcinkowski P; Osterland M; Herrmann P; Smith J; Heizmann CW; Schlag PM; Stein U
    Oncotarget; 2014 May; 5(10):3220-33. PubMed ID: 24952599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancer.
    Stein U; Arlt F; Walther W; Smith J; Waldman T; Harris ED; Mertins SD; Heizmann CW; Allard D; Birchmeier W; Schlag PM; Shoemaker RH
    Gastroenterology; 2006 Nov; 131(5):1486-500. PubMed ID: 17101323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear S100A4 is a novel prognostic marker in colorectal cancer.
    Boye K; Nesland JM; Sandstad B; Mælandsmo GM; Flatmark K
    Eur J Cancer; 2010 Nov; 46(16):2919-25. PubMed ID: 20719498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of calcium-binding protein S100A4 in colorectal cancer.
    Gongoll S; Peters G; Mengel M; Piso P; Klempnauer J; Kreipe H; von Wasielewski R
    Gastroenterology; 2002 Nov; 123(5):1478-84. PubMed ID: 12404222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of S100A4 mRNA and protein expression in colorectal cancer.
    Kang YG; Jung CK; Lee A; Kang WK; Oh ST; Kang CS
    J Surg Oncol; 2012 Feb; 105(2):119-24. PubMed ID: 21837681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Podoplanin, α-smooth muscle actin or S100A4 expressing cancer-associated fibroblasts are associated with different prognosis in colorectal cancers.
    Choi SY; Sung R; Lee SJ; Lee TG; Kim N; Yoon SM; Lee EJ; Chae HB; Youn SJ; Park SM
    J Korean Med Sci; 2013 Sep; 28(9):1293-301. PubMed ID: 24015033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inverse expression of S100A4 and E-cadherin is associated with metastatic potential in gastric cancer.
    Yonemura Y; Endou Y; Kimura K; Fushida S; Bandou E; Taniguchi K; Kinoshita K; Ninomiya I; Sugiyama K; Heizmann CW; Schafer BW; Sasaki T
    Clin Cancer Res; 2000 Nov; 6(11):4234-42. PubMed ID: 11106237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S100A4 over-expression underlies lymph node metastasis and poor prognosis in colorectal cancer.
    Huang LY; Xu Y; Cai GX; Guan ZQ; Sheng WQ; Lu HF; Xie LQ; Lu HJ; Cai SJ
    World J Gastroenterol; 2011 Jan; 17(1):69-78. PubMed ID: 21218086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of S100A4 expression in stage II and III colorectal cancer: results from a population-based series and a randomized phase III study on adjuvant chemotherapy.
    Boye K; Jacob H; Frikstad KA; Nesland JM; Maelandsmo GM; Dahl O; Nesbakken A; Flatmark K
    Cancer Med; 2016 Aug; 5(8):1840-9. PubMed ID: 27273130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S100A4 Is a Strong Negative Prognostic Marker and Potential Therapeutic Target in Adenocarcinoma of the Stomach and Esophagus.
    Treese C; Hartl K; Pötzsch M; Dahlmann M; von Winterfeld M; Berg E; Hummel M; Timm L; Rau B; Walther W; Daum S; Kobelt D; Stein U
    Cells; 2022 Mar; 11(6):. PubMed ID: 35326507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RPS12-specific shRNA inhibits the proliferation, migration of BGC823 gastric cancer cells with S100A4 as a downstream effector.
    Chen D; Zhang R; Shen W; Fu H; Liu S; Sun K; Sun X
    Int J Oncol; 2013 May; 42(5):1763-9. PubMed ID: 23546393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of S100A4-expression and subcellular localization in early-stage breast cancer.
    Egeland EV; Boye K; Park D; Synnestvedt M; Sauer T; ; Naume B; Borgen E; Mælandsmo GM
    Breast Cancer Res Treat; 2017 Feb; 162(1):127-137. PubMed ID: 28058579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.